Squarepoint
ABEO icon

Squarepoint’s Abeona Therapeutics ABEO Stock Holding History

Squarepoint’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$65.9K Buy
+12,550
New +$77.9K ﹤0.01% 4265
2025
Q4 		– Sell
-21,316
Closed -$113K – 4190
2025
Q3 		$113K Sell
21,316
-120,662
-85% -$765K ﹤0.01% 4087
2025
Q2 		$806K Buy
141,978
+104,037
+274% +$592K ﹤0.01% 2855
2025
Q1 		$181K Buy
37,941
+25,913
+215% +$141K ﹤0.01% 4052
2024
Q4 		$67K Buy
+12,028
New +$74K ﹤0.01% 4790
2024
Q2 		– Sell
-14,520
Closed -$105K – 3979
2024
Q1 		$105K Buy
14,520
+4,520
+45% +$28.6K ﹤0.01% 3789
2023
Q4 		$50.1K Buy
+10,000
New +$44K ﹤0.01% 3848
2022
Q3 		– Sell
-568
Closed -$3K – 2931
2022
Q2 		$3K Buy
568
+77
+16% +$390 ﹤0.01% 2806
2022
Q1 		$4K Hold
491
– – ﹤0.01% 2734
2021
Q4 		$4K Buy
+491
New +$9.02K ﹤0.01% 3108
2021
Q2 		– Sell
-532
Closed -$25K – 3158
2021
Q1 		$25K Sell
532
-1,949
-79% -$107K ﹤0.01% 3021
2020
Q4 		$97K Sell
2,481
-1,331
-35% -$45.3K ﹤0.01% 2727
2020
Q3 		$97K Buy
3,812
+2,920
+327% +$184K ﹤0.01% 2296
2020
Q2 		$65K Sell
892
-88
-9% -$6.08K ﹤0.01% 2073
2020
Q1 		$51K Buy
+980
New +$65.5K ﹤0.01% 1718
2019
Q3 		– Sell
-1,970
Closed -$235K – 2294
2019
Q2 		$235K Buy
+1,970
New +$330K ﹤0.01% 2044
2019
Q1 		– Sell
-475
Closed -$85K – 2100
2018
Q4 		$85K Sell
475
-437
-48% -$95.3K ﹤0.01% 1811
2018
Q3 		$292K Buy
+912
New +$324K ﹤0.01% 1552

Other funds holding ABEO

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $854M AUM 179.73% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Panagora Asset Management
Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Squarepoint's ABEO Position: Q3 2026 in Review

Squarepoint opened a new position in Abeona Therapeutics (ABEO) in Q3 2026: 12,550 shares worth $65.9K. The stake represents ﹤0.01% of the portfolio and ranks #4265 among its holdings. This is a return to the name: Squarepoint previously reported a position in ABEO as recently as Q3 2025.

Squarepoint first reported a position in ABEO in Q3 2018 and has held it in 18 quarters since. The position peaked at $806K in Q2 2025. 54 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

  • Squarepoint held 12,550 shares of Abeona Therapeutics worth $65.9K as of Q3 2026.
  • Abeona Therapeutics was a new Squarepoint position in Q3 2026.
  • Abeona Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #4265 holding.
  • Squarepoint first reported a position in Abeona Therapeutics in Q3 2018 and has held it in 18 quarters since.
  • Squarepoint's Abeona Therapeutics position peaked at $806K in Q2 2025.
  • 54 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.